Print Icon
 

Issue 6 | July 2023

Welcome from Vicky, Annette and Jo

Welcome to the July 2023 edition of the East Genomic Medical Service Alliance (GMSA) Nursing and Midwifery Genomics Newsletter. In this edition, we focus on:

  • the Newborn Genomes Programme
  • the role of health visitors in genomics
  • #GenomicsConversation week
  • an update on our polycystic kidney disease work programme.

Please share this newsletter with colleagues and encourage them to sign up to receive it here.

Vicky Carr 

East GMSA Nurse Lead
Cambridge University Hospitals

Annette Breen

East GMSA Nurse Lead

Nottingham University Hospitals

Joanne Hargrave

East GMSA Midwife Lead

Norfolk and Norwich University Hopsitals

Jon the #GenomicsConversation 26-30 June

Today marks the start of the annual Genomics Conversation campaign. This year's theme is how genomics can feel ‘hidden’ for many professionals and their patients.

 

Hosted by the National Genomics Education Programme, the week will feature stories and activities that reveal how genomics is being used across the healthcare system, and will uncover the unexpected places in which genomics can appear for both healthcare professionals and patients. Lookout for new resources, films, infographics and powerful stories, all designed to encourage you to discover genomics in your own practice. A calendar of activities is available, so you can follow the action on each day.

 

To get involved in the conversation, visit the dedicated campaign webpage.


For the East region we are putting in two sessions to mark the week: 

Meet Sally Shillaker

Sally is Clinical Content Developer at Genomics England. She is a nurse and health visitor seconded to the Genomics England Newborn Genomes Programme. Sally tells us more about the Programme, the planned research study and what this means for babies, their families and health care professionals.


Sally also has experience of recruiting to the 100,000 Genomes Project and working with the Institute of Health Visiting and Health Education England to develop genomic resources.

The Newborn Genomes Programme


What is it?

Genomics England’s Newborn Genomes Programme is delivering a large-scale NHS-embedded research study called the Generation Study.  This will start at the end of this year subject to research ethics committee approvals.  


The study is being co-produced with, and involving, potential participants, healthcare professionals, researchers, patient organisations, and members of the public. Co-production is central to the Generation Study. This approach is supporting the Newborn Genomes Programme to deliver and design the study with stakeholders’ views, interests, and concerns in mind.


It is estimated that 1 in 17 people will develop a rare genetic condition during their lifetime.[1] These conditions are often diagnosed in early childhood, but diagnoses can take a long time, leading to “diagnostic odysseys” that can be difficult for children and their families. 


“Diagnostic odyssey” is a term used in genomics to describe the often long period of time it can take for a patient to receive a diagnosis for their condition.  Sometimes patients will have many different medical tests and investigations, which may be painful and invasive.  These contribute to the patient’s “diagnostic odyssey” which may last many years and include several misdiagnoses.  Genomic testing to identify and diagnose rare genetic conditions earlier in newborn babies has the potential to mitigate these “diagnostic odysseys”[2], so that, where appropriate, NHS treatments or interventions could be offered sooner


What are the aims of study?

The Newborn Genomes Programme’s Generation Study will aim to:

  1. explore the benefits, challenges, and feasibility of sequencing newborns’ genomes for a larger number of childhood-onset rare genetic conditions
  2. understand how babies’ genomic data could be used for discovery research, focusing on developing new treatments and diagnostics for NHS patients
  3. explore the potential risks, benefits, and broader implications of storing a baby's genome over their lifetime

The study will run alongside the routine newborn blood spot screening programme (heel prick test), which is currently offered to all babies in the UK and tests them for 9 rare conditions.[3] The Generation Study will use genome-sequencing technology to look for around 200 rare genetic conditions. The conditions included in the study occur in early childhood and have an intervention that would be available in the NHS and that could either cure, delay, or modify the course of the condition.[4]


Where will the study take place?

The Government has awarded Genomics England £105m to deliver the study across a selection of NHS Trusts in England.[5] At least one Trust from each of the seven GMSA (Genomic Medicine Service Alliance) regions will be invited to join the study. These Trusts will be carefully chosen to make sure they vary in size and setting and are spread across England. It is likely that the study will only run in 5-6 trusts in the first instance, with more joining the study later in 2024.


At participating Trusts, parents will be invited to take part in the study about halfway through their pregnancy, so that they have time to make an informed decision before their baby is born.


Who will be invited to participate in the study?

Mothers or birthing parents at the study sites will be able to agree to their babies’ participation in the Generation Study if they:

  • Are 16 years or older
  • Have an NHS number
  • Are able to consent to their own medical treatment
  • Are pregnant with only one baby (not twins or triplets) - however, it is expected that multiple pregnancies will be included later in the study.
  • Have a permanent home address where they live currently
The Generation Study has been designed to give plenty of time for babies’ families to ask questions and consider their participation in the study during the pregnancy or birthing period.


How and when will samples be taken?
In 2022, the Newborn Genomes Programme ran the “Baby and Mum Samples Study” to identify the best way to take a sample from a baby to sequence their genome.[6]  The diagram below shows how samples for The Generation Study will be collected.

Will families be informed of the results?

The study aims for results to be available 2 weeks after sample collection when sequencing and analysis is complete. In the early phases of the study, the time for results may be longer than this.

 

The baby’s parents will receive one of two possible results:

  • If their baby is thought to have a rare genetic condition, an NHS specialist will contact them to explain the results and the next steps for their baby’s care.
  • If none of the conditions screened for are suspected, parents will be informed by letter.

After parents have been sent their baby’s results, they will receive updates on the study and be invited to volunteer to share their experiences of the study and offer feedback.

 

The data collected from babies will be stored in the National Genomic Research Library (NGRL), a secure national database of de-identified genomic and health data managed by Genomics England.[7]

 

Babies’ parents will be able to withdraw from The Generation Study at any time.


What support is available for healthcare professionals?

Healthcare professionals at the participating NHS Trusts will play a major role in the delivery of The Generation Study. We are designing a competency-based education and training framework to ensure that every healthcare professional who is involved is equipped, and feels confident, to support families who participate.  Training sessions will be key, which healthcare professionals working on the Newborn Genomes Programme will design and help to deliver.

 

The Newborn Genomes Programme will also fund specific roles that will be created to support the Generation Study. These will be advertised in the coming months.

 

You can find out more about the Newborn Genomes Programme hereIf you have any questions, contact: ge-newborns@genomicsengland.co.uk

Genomic BITEs: Newborn Genomes Programme's Generation Study

Our next Genomics BITE session will focus on Newborn Genomes Programme's Generation Study and takes place on Wednesday 4 July, 12.30pm - 1.30pm via MS Teams. You can register your free place here.


Our previous Nursing and Midwifery Genomics BITE sessions are now available to watch on our YouTube channel:

We will be having a break in August and return with more Genomics BITE sessions from September. To suggest a session that would be of interest to you please contact Annette Breen.

Genomics in health visiting

Advances in genomics are moving ahead rapidly and will change the way that health visiting teams support families in the future. The National Genomics Education Team is working with the Institute of Health Visiting to ensure that practitioners are ready for this. 

 

They need to hear from health visitors, so if that's you, please complete their survey by Monday 17 July. Your responses will help to support the development of bespoke training for health visiting. The survey should take no more than 20 minutes to complete and contains questions about your current role and some practice based scenarios and questions. For the scenario questions, don’t worry if you don’t do some of the visits included, you can still answer the questions based on your wider experiences, to capture your likely responses.


All the information collected will be stored securely and your responses will be anonymised. Thank you in advance for your participation and help with this. Please do share this survey with your health visitor colleagues and health visiting team members.

Polycystic Kidney Disease Work Programme

Join our fifth and final polycystic kidney disease national workshop on Monday 17 July 2023, 2pm – 4pm via MS Teams to hear about our outputs, incluidng:

  • patient stories
  • infographic which gives an overview of polycystic kidney disease genomic testing across the lifespan
  • Renal GeNotes to healthcare professionals make the right genomics decisions at each stage of a clinical pathway
  • Clinical pathway initiative
Scan the QR code in the image to download the Outlook invite, or alternatively email pauline.simpson@nnuh.nhs.uk.

Education, Training and Resources

The Genomics Education Programme has a wide range of free to access learning and education resources for nurses, midwives and health visitors.  No matter where you are in your leaning journey about genomics, there is something for you to build your knowledge and support your NMC revalidation including:

  • Bite size genomics a series of 10 minute animations and films
  • Genomics 101 a series of 9 short introductory courses, each lasting about 30 minutes for those with a little bit or no knowledge about genomics
  • Taught courses up to Masters level
  • GeNotes help healthcare professionals make the right genomics decisions at each stage of a clinical pathway. GeNotes are in development to provide:
    • In The Clinic information focussed at the point of patient care with clinical scenarios, when to consider genomic testing, what you need to do and the results stage
    • Knowledge Hub accessed via links within ‘In The Clinic’ to external sources and resources and signpost to relevant guidelines, including NICE.

GeNotes are organised into clinical specialities and will be released in a phased manner.  There are currently some Oncology and Fetal and Women’s Health clinical presentations and summaries available to support you in your practice.

Meet the East GMSA Nursing and Midwifery Team

Contact: Melissa Cambell-Kelly, Annette Breen, Vicky Carr, Jo Hargrave or Katy Blakely. We also have a network of LINK Nurses across our 29 Partner Trusts. If would like to know who your local Genomic LINK Nurse is, contact us here.

Useful links

If you would like to unsubscribe to these newsletters please email us